SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 21st, 2024 • Invizyne Technologies Inc • Biological products, (no disgnostic substances) • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of the ___ day of __________ 2024, by and among INVIZYNE Technologies Inc., a Nevada corporation (the “Company”) and [________] each individual or entity named on the Schedule of Buyers attached hereto (each such individual or entity, individually, a “Buyer” and all of such individuals or entities, collectively, the “Buyers”).
WARRANT TO PURCHASE COMMON STOCK INVIZYNE TECHNOLOGIES INC.Placement Warrant Agreement • October 21st, 2024 • Invizyne Technologies Inc • Biological products, (no disgnostic substances)
THIS WARRANT TO PURCHASE COMMON STOCK (the “Warrant”) certifies that, for the purchase price of $0.125 per Warrant, or an aggregate of $___ , [Name of holder]_____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the six (6) months anniversary of the effective date of the registration statement filed with the Commission (hereinafter defined) for the initial public offering of the Company (the “Initial Exercise Date”) and prior to at 5:00 p.m. (New York time) on the date that is five (5) years following the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Invizyne Technologies Inc., a Nevada corporation (the “Company”), up to ______ shares of Common Stock, par value $0.000001 per share, of the Company (the “Warrant Shares”), as subject to adjustment hereunder. The purchase price of one share of Common Stock under this
